Emergent BioSolutions
EBS
A$9.97
Share price
-4.13%
Change (1 day)
-55.82%
Change (1 year)
Categories
EPS for Emergent BioSolutions (EBS)
EPS in 2025 (TTM): A-$3.87
According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is A-$3.91. In 2024 the company made an earnings per share (EPS) of A-$5.57 an increase over its 2023 EPS that were of A-$22.84.
EPS history for Emergent BioSolutions from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | A-$3.87 | -30.57% |
| 2024 | A-$5.57 | -75.61% |
| 2023 | A-$22.84 | 232.21% |
| 2022 | A-$6.88 | -203.46% |
| 2021 | A$6.64 | -25.09% |
| 2020 | A$8.87 | 445.28% |
| 2019 | A$1.63 | -15.2% |
| 2018 | A$1.92 | -35.9% |
| 2017 | A$2.99 | 69.57% |
| 2016 | A$1.76 | -27.67% |
| 2015 | A$2.44 | 65.63% |
| 2014 | A$1.47 | 11.63% |
| 2013 | A$1.32 | 32.31% |
| 2012 | A$1.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Merck MRK | A$10.58 | -370.48% | 🇺🇸 USA |
 SIGA Technologies SIGA | A$0.28 | -107.06% | 🇺🇸 USA |
 GlaxoSmithKline GSK | A$2.39 | -161.17% | 🇬🇧 UK |
 Celldex Therapeutics CLDX | A-$4.14 | 5.88% | 🇺🇸 USA |
 Pfizer PFE | A$2.13 | -154.51% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | A-$1.75 | -55.29% | 🇮🇱 Israel |
 Soligenix SNGX | A-$9.30 | 137.65% | 🇺🇸 USA |